Vanguard Capital Management’s Cardio Diagnostics CDIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.3K Hold
20,155
– – ﹤0.01% 3933
2026
Q2
$44.1K Hold
20,155
– – ﹤0.01% 3946
2026
Q1
$39.3K Buy
+20,155
New +$52.7K ﹤0.01% 3943

Other funds holding CDIO

Vanguard Capital Management's CDIO Position: Q3 2026 in Review

Vanguard Capital Management held its Cardio Diagnostics (CDIO) position steady in Q3 2026 at 20,155 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3933.

Vanguard Capital Management first reported a position in CDIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $44.1K in Q2 2026. 13 funds tracked by Wall St. Rank hold CDIO as of Q3 2026.

  • Vanguard Capital Management held 20,155 shares of Cardio Diagnostics worth $38.3K as of Q3 2026.
  • Vanguard Capital Management left its Cardio Diagnostics share count unchanged in Q3 2026.
  • Cardio Diagnostics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3933 holding.
  • Vanguard Capital Management first reported a position in Cardio Diagnostics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Cardio Diagnostics position peaked at $44.1K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.